Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia-Reference-Cited by-同舟云学术

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

Published:2016-09-08 Issue:10 Volume:128 Page:1408-1417
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Elena Chiara¹²,Gallì Anna²,Such Esperanza³,Meggendorfer Manja⁴,Germing Ulrich⁵,Rizzo Ettore⁶,Cervera Jose³,Molteni Elisabetta¹,Fasan Annette⁴,Schuler Esther⁵,Ambaglio Ilaria²,Lopez-Pavia Maria³,Zibellini Silvia²,Kuendgen Andrea⁵,Travaglino Erica²,Sancho-Tello Reyes⁷,Catricalà Silvia²,Vicente Ana I.⁸,Haferlach Torsten⁴,Haferlach Claudia⁴,Sanz Guillermo F.³,Malcovati Luca¹²,Cazzola Mario¹²

Affiliation:

1. Department of Molecular Medicine, University of Pavia, Pavia, Italy;

2. Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;

3. Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain;

4. Munich Leukemia Laboratory GmbH, Munich, Germany;

5. Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany;

6. Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy;

7. Department of Hematology, Hospital Arnau de Vilanova, Valencia, Spain; and

8. Department of Hematology, Hospital de La Ribera, Alzira, Spain

Abstract

Key Points Risk assessment is crucial in patients with CMML because survival may range from a few months to several years. Integrating clinical features, morphology, and genetic lesions significantly improves risk stratification in CMML.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/128/10/1408/1394777/1408.pdf

Reference44 articles.

1. Introduction and overview of the classification of the myeloid neoplasms.;Vardiman,2008

2. Myelodysplastic/myeloproliferative neoplasms.;Cazzola;Hematology Am Soc Hematol Educ Program,2011

3. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia.;Bennett;Br J Haematol,1994

4. Chronic myelomonocytic leukaemia.;Vardiman,2008

5. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.;Arber;Blood,2016

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between myeloid disorders and adult onset-inflammatory syndromes, successful treatment with JAK-inhibitors: Case series and literature review;Leukemia Research;2024-11

2. Incorporation mutational profile might reduce the importance of blast count in prognostication of low‐risk myelodysplastic syndromes;British Journal of Haematology;2024-08-28

3. MDS patient registries - achievements and challenges;Annals of Hematology;2024-08-23

4. Recent Advances in the Molecular Pathogenesis and Diagnosis of Chronic Myelomonocytic Leukemia;Advances in Molecular Pathology;2024-08

5. Leveraging a neutrophil-derived PCD signature to predict and stratify patients with acute myocardial infarction: from AI prediction to biological interpretation;Journal of Translational Medicine;2024-07-02